Skip to main content
Clinical Trials/NCT01477125
NCT01477125
Completed
N/A

Computerised Working Memory Training in Adults With ADHD: A Randomised Controlled Trial

Karolinska Institutet1 site in 1 country102 target enrollmentNovember 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Karolinska Institutet
Enrollment
102
Locations
1
Primary Endpoint
Change in a composite measure of working memory capacity
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to evaluate whether computerised working memory training improves cognitive performance, ADHD symptoms, psychosocial functioning and quality of life in adults with ADHD, from psychiatric outpatient clinics (N=100) as well as from a high-security prison facility (N=50).

Detailed Description

The primary aim is to evaluate whether 5 weeks of computerised working memory training improves working memory capacity. Secondary aims are to explore whether improvements in working memory capacity will be transferred to improvements in learning abilities and fluid intelligence. Also, far transfer effects on executive functioning, ADHD symptoms, psychosocial functioning and quality of life will be explored. Finally, it will also be assessed to what extent improvements gained from 5 weeks of working memory training will be maintained 3 and 6 months post-study, respectively.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
June 15, 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ylva Ginsberg, MD, PhD

Senior consultant psychiatrist, clinical postdoc

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Confirmed ADHD according to DSM-IV criteria; ADHD combined type, ADHD inattentive type or ADHD UNS, primarily inattentive type.
  • Unmedicated for ADHD during the course of the trial, or being under stable ADHD medication for at least one month at baseline visit and without any planned changes in medication until post-study assessments have taken place.

Exclusion Criteria

  • Previous participation in computerised working memory training (completed training).
  • Any psychiatric disorder that in the judgment of the investigator, may interfere with study participation and/or study assessments, also including current substance abuse.
  • Participation in psychological treatment addressing ADHD during the course of the 5-week training period (psychoeducation is accepted).
  • Initiation of psychological treatment for coexistent disorders during the course of the study (treatment already ongoing at baseline visit is accepted if there are no planned changes during the 5-week training period).

Outcomes

Primary Outcomes

Change in a composite measure of working memory capacity

Time Frame: Baseline and 7 weeks

The composite measure of working memory capacity comprises the sum score of: * Digit Span score (forwards/backwards) * Span Board score (forwards/backwards) * Arithmetics score * Spatial Working Memory score

Secondary Outcomes

  • Change in Digit Span Forwards/Backwards score(Baseline, 7 and 31 weeks)
  • Change in Arithmetics score(Baseline, 7 and 31 weeks)
  • Change in Qbtest scores(Baseline, 7 and 31 weeks)
  • Change in a composite measure of working memory capacity(Baseline and 31 weeks)
  • Change in EuroQol- 5 Dimensions (EQ-5D) questionnaire(Baseline, 7, 19, and 31 weeks)
  • Montgomery Åsberg Depression Rating Scale-Self report (MADRS-S)(Baseline and 7 weeks)
  • Change in Span Board Forwards/Backwards score(Baseline, 7 and 31 weeks)
  • Change in Spatial Working Memory score(Baseline, 7 and 31 weeks)
  • Change in Sheehan Disability Scale (SDS)(Baseline, 7, 19, and 31 weeks)
  • Change in Raven´s Standard Progressive Matrices score(Baseline, 7 and 31 weeks)
  • Change in Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist(Baseline, 7, 19, and 31 weeks)
  • Change in Adult ADHD Quality of Life Measure (AAQoL)(Baseline, 7, 19, and 31 weeks)
  • Adverse events(Baseline and 7 weeks)

Study Sites (1)

Loading locations...

Similar Trials